CEFI’s position. Changes in the National Health System in favor of innovation, efficiency and service to patients
CEFI’s position. Transparency regarding drug prices.
Manufacturing waiver for the exportation of SPC VS. protection of industrial property and biometrics innovation.
The transparency of drug prices. Current context and legal analysis.
Questions and answers on biological and biosimilar medicines.
This post is also available in: Spanish